Bioventus launches $60 million second-lien term loan at 10½% area

By Sara Rosenberg

New York, Sept. 9 – Bioventus launched on Tuesday its $60 million six-year second-lien term loan with price talk in the 10½% all-in-yield area, according to a market source.

The loan has call protection of 102 in year one and 101 in year two, the source said.

J.P. Morgan Securities LLC is the lead bank on the deal.

Proceeds will be used to refinance existing debt.

Bioventus is a Durham, N.C.-based orthopedic healing company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.